Letting older patients see the same GP reduces the likelihood of hospital admission

Letting older patients see the same GP reduces the likelihood of hospital admission

May 24 2018 Patients who see the same GP over time are admitted to hospital less often than...

Prescription numbers in Wales increase 0.2%

Prescription numbers in Wales increase 0.2%

May 24 2018 The number of prescription items dispensed in Wales increased 0.2% from 80.3 million...

GMC consults on reflective practice guidance and improves fitness to practise process

GMC consults on reflective practice guidance and improves fitness to practise process

May 23 2018 The General Medical Council is to work with medical professional bodies to produce...

RCGP Wales launches survey with a third of GPs saying stress impacts significantly on their practice

RCGP Wales launches survey with a third of GPs saying stress impacts significantly on their practice

May 23 2018 Almost one in three GPs (32%) are so stressed they feel they cannot cope at least...

New website launched to support people with atopic dermatitis

New website launched to support people with atopic dermatitis

May 22 2018 ‘Scratch Beneath the Surface’, a new UK public health initiative intended...

  • Letting older patients see the same GP reduces the likelihood of hospital admission

    Letting older patients see the same GP reduces the likelihood of hospital admission

    Thursday, 24 May 2018 15:57
  • Prescription numbers in Wales increase 0.2%

    Prescription numbers in Wales increase 0.2%

    Thursday, 24 May 2018 15:48
  • GMC consults on reflective practice guidance and improves fitness to practise process

    GMC consults on reflective practice guidance and improves fitness to practise process

    Wednesday, 23 May 2018 14:12
  • RCGP Wales launches survey with a third of GPs saying stress impacts significantly on their practice

    RCGP Wales launches survey with a third of GPs saying stress impacts significantly on their practice

    Wednesday, 23 May 2018 14:08
  • New website launched to support people with atopic dermatitis

    New website launched to support people with atopic dermatitis

    Tuesday, 22 May 2018 13:14

adhdDecember 2 2015

Researchers have urged doctors to be cautious if considering prescribing methylphenidate for children or adolescents with attention deficit hyperactivity disorder (ADHD).

A Cochrane review has concluded that the drug may improve teacher-reported ADHD symptoms, teacher-reported general behaviour, and parent-reported quality of life among children and adolescents diagnosed with ADHD. “However, the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects.”

The researchers assessed 38 parallel-group trials and 147 cross-over trials, representing over 12,200 patients, and found methylphenidate led to “modest” improvements in ADHD symptoms as a primary outcome. They also found there were improvements in general behaviour and quality of life. However, in all outcomes, the quality of the evidence was judged to be “very low”.

Data for serious adverse events was only reported in nine out of the 185 trials, meaning that while methylphenidate does not appear to be associated with an increased risk of serious adverse events, the quality of the evidence was again very low.

“It was apparent from assessing the included trials that it would have been possible for people involved in the trials to have been aware of which treatment the children were taking,” says Cochrane. “In addition, the reporting of results was not complete in many of the trials, and for some analyses there was variation among trial results.

“Based upon this information, the researchers urge clinicians to be cautious in prescribing methylphenidate, and to weigh up the benefits and risks more carefully.”

Professor Ole Jakob Storebø, a clinical psychologist from the Psychiatric Research Unit in Region Zealand, Denmark, led the team of 18 researchers carrying out the meta-analysis. “This review highlights the need for long-term, large, better-quality randomized trials so that we can determine the average effect of this drug more reliably,” he said.

Co-author Camilla Groth MD added: “This review shows very limited quality evidence for the effects of methylphenidate on children and adolescents with ADHD. Some might benefit, but we still don’t know which patients will do so. Clinicians prescribing methylphenidate must take account of the poor quality of the evidence, monitor treatment carefully, and weigh up the benefits and adverse effects.”

Links:

Cochrane announcement

Cochrane review summary

Ole Jakob Storebø et al. ‘Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)’. Cochrane Library. Published online November 25 2015.

Professional News

May 24 2018 Patients who see the same GP over time are admitted to hospital less often than similar individuals who see the same GP less often, a report has noted.
May 24 2018 Patients who see the same GP over time are admitted to hospital less often than similar individuals who see the same GP less often, a report has noted. The Health Foundation has examined...